Hologic Inc. (HOLX)
NASDAQ: HOLX
· Real-Time Price · USD
67.21
1.42 (2.16%)
At close: Sep 26, 2025, 3:59 PM
67.58
0.55%
After-hours: Sep 26, 2025, 06:34 PM EDT
Hologic Revenue Breakdown
| Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 28, 2024 | Jun 29, 2024 | Jun 30, 2018 | Mar 31, 2018 | Dec 30, 2017 | Sep 30, 2017 | Jul 1, 2017 | Apr 1, 2017 | Dec 31, 2016 | Sep 24, 2016 | Jun 25, 2016 | Mar 26, 2016 | Dec 26, 2015 | Sep 26, 2015 | Jun 27, 2015 | Mar 28, 2015 | Dec 27, 2014 | Sep 27, 2014 | Jun 28, 2014 | Mar 29, 2014 | Dec 28, 2013 | Sep 28, 2013 | Jun 29, 2013 | Mar 30, 2013 | Dec 29, 2012 | Sep 29, 2012 | Jun 23, 2012 | Mar 24, 2012 | Dec 24, 2011 | Sep 24, 2011 | Jun 25, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breast Health Revenue | 365.2M | 356.2M | 369.1M | 385M | 307.9M | 300.1M | 288M | 300.9M | 283.7M | 280.5M | 273.3M | 292.3M | 282.5M | 275.8M | 262.2M | 286.4M | 279.5M | 255.5M | 242M | 241.5M | 238M | 238.71M | 226.49M | 234.19M | 230.02M | 220.06M | 220.81M | 230.33M | 211.46M | 218.63M | 215.35M | 620.37M | 205.19M |
| Breast Health Revenue Growth | +2.53% | -3.49% | -4.13% | +25.04% | +2.60% | +4.20% | -4.29% | +6.06% | +1.14% | +2.63% | -6.50% | +3.47% | +2.43% | +5.19% | -8.45% | +2.47% | +9.39% | +5.58% | +0.21% | +1.47% | -0.30% | +5.39% | -3.29% | +1.82% | +4.53% | -0.34% | -4.13% | +8.92% | -3.28% | +1.52% | -65.29% | +202.34% | n/a |
| Diagnostics Revenue | 448.9M | 453.6M | 470.6M | 440.8M | 294.2M | 279.7M | 284.6M | 291.7M | 284.1M | 296M | 325.4M | 311.9M | 309.9M | 304.4M | 310.7M | 304.1M | 306.9M | 296.7M | 304.1M | 317.13M | 293.1M | 290.8M | 285.77M | 289.98M | 297.42M | 296.51M | 305.92M | 253.45M | 158.71M | 151.84M | 154.06M | 427.82M | 143.45M |
| Diagnostics Revenue Growth | -1.04% | -3.61% | +6.76% | +49.83% | +5.18% | -1.72% | -2.43% | +2.68% | -4.02% | -9.04% | +4.33% | +0.65% | +1.81% | -2.03% | +2.17% | -0.91% | +3.44% | -2.43% | -4.11% | +8.20% | +0.79% | +1.76% | -1.45% | -2.50% | +0.31% | -3.08% | +20.70% | +59.69% | +4.52% | -1.44% | -63.99% | +198.24% | n/a |
| Gyn Surgical Revenue | 178.4M | 162.5M | 166.3M | 166.6M | 107.7M | 99.4M | 107.5M | 104.7M | 106.5M | 101.1M | 114.8M | 101.4M | 102M | 90.9M | 98.8M | 86.8M | 85.5M | 79.1M | 84.4M | 78.5M | 78.5M | 72.04M | 78.85M | 76.7M | 75.83M | 73.69M | 80.91M | 79.69M | 77.67M | 77.18M | 78.55M | 221.19M | 79.35M |
| Gyn Surgical Revenue Growth | +9.78% | -2.29% | -0.18% | +54.69% | +8.35% | -7.53% | +2.67% | -1.69% | +5.34% | -11.93% | +13.21% | -0.59% | +12.21% | -8.00% | +13.82% | +1.52% | +8.09% | -6.28% | +7.51% | 0.00% | +8.96% | -8.64% | +2.80% | +1.14% | +2.91% | -8.92% | +1.52% | +2.60% | +0.64% | -1.74% | -64.49% | +178.74% | n/a |
| Skeletal Health Revenue | 31.3M | 33M | 15.8M | 19M | 22.5M | 24.6M | 19.7M | 24.2M | 21.8M | 21.8M | 20.9M | 21.2M | 23M | 22.2M | 23.5M | 25.5M | 22M | 24.2M | 22.3M | 23.5M | 23M | 23.46M | 21.34M | 21.24M | 22.87M | 22.41M | 23.73M | 25.08M | 22.39M | 23.52M | 24.75M | 68.9M | 23.1M |
| Skeletal Health Revenue Growth | -5.15% | +108.86% | -16.84% | -15.56% | -8.54% | +24.87% | -18.60% | +11.01% | 0.00% | +4.31% | -1.42% | -7.83% | +3.60% | -5.53% | -7.84% | +15.91% | -9.09% | +8.52% | -5.13% | +2.20% | -1.95% | +9.94% | +0.45% | -7.12% | +2.07% | -5.58% | -5.38% | +12.02% | -4.80% | -4.99% | -64.08% | +198.29% | n/a |
Revenue by Geography
| Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Sep 24, 2022 | Jun 25, 2022 | Mar 26, 2022 | Dec 25, 2021 | Sep 25, 2021 | Jun 26, 2021 | Mar 27, 2021 | Dec 26, 2020 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Dec 28, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 29, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States Revenue | 760.7M | 744.9M | 757.9M | 745.7M | 765.3M | 759.4M | 753.7M | 715.6M | 750.1M | 768.7M | 823.6M | 728.5M | 734.6M | 992.4M | 1.01B | 950.6M | 749.9M | 1.06B | 1.14B | 246.9M | 101.7M | 111.8M | 109.4M | 96.9M | 95.9M | 102.1M | 101.1M |
| United States Revenue Growth | +2.12% | -1.72% | +1.64% | -2.56% | +0.78% | +0.76% | +5.32% | -4.60% | -2.42% | -6.67% | +13.05% | -0.83% | -25.98% | -1.98% | +6.50% | +26.76% | -29.52% | -6.49% | +360.83% | +142.77% | -9.03% | +2.19% | +12.90% | +1.04% | -6.07% | +0.99% | n/a |
| Europe Revenue | 148.1M | 146.5M | 148.9M | 125M | 127.9M | 137M | 142.8M | 92.9M | 128.5M | 151.5M | 147.4M | 137.7M | 164.5M | 291.2M | 295.1M | 237.8M | 289M | 336.8M | 338.2M | n/a | 16.7M | 27.7M | 38.2M | n/a | 37.8M | 36.5M | 38.2M |
| Europe Revenue Growth | +1.09% | -1.61% | +19.12% | -2.27% | -6.64% | -4.06% | +53.71% | -27.70% | -15.18% | +2.78% | +7.04% | -16.29% | -43.51% | -1.32% | +24.10% | -17.72% | -14.19% | -0.41% | n/a | n/a | -39.71% | -27.49% | n/a | n/a | +3.56% | -4.45% | n/a |
| Asia-Pacific Revenue | 60.3M | 59.7M | 59.8M | 66.4M | 65M | 64.4M | 63.8M | 63.8M | 62.9M | 65.2M | 63.8M | 58.6M | 71.7M | 109.7M | 119.7M | 97M | 89.6M | 90.1M | 88.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Asia-Pacific Revenue Growth | +1.01% | -0.17% | -9.94% | +2.15% | +0.93% | +0.94% | 0.00% | +1.43% | -3.53% | +2.19% | +8.87% | -18.27% | -34.64% | -8.35% | +23.40% | +8.26% | -0.55% | +2.04% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Rest Of World Revenue | 54.7M | 54.2M | 55.2M | 50.9M | 53.2M | 57M | 52.8M | 73M | 42.9M | 41.1M | 39.4M | 28.5M | 31.9M | 42.4M | 43.9M | 31.2M | 39.8M | 46.7M | 45.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Rest Of World Revenue Growth | +0.92% | -1.81% | +8.45% | -4.32% | -6.67% | +7.95% | -27.67% | +70.16% | +4.38% | +4.31% | +38.25% | -10.66% | -24.76% | -3.42% | +40.71% | -21.61% | -14.78% | +2.64% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Sep 24, 2022 | Jun 25, 2022 | Mar 26, 2022 | Dec 25, 2021 | Sep 25, 2021 | Jun 26, 2021 | Mar 27, 2021 | Dec 26, 2020 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Dec 28, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 29, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 30, 2017 | Sep 30, 2017 | Jul 1, 2017 | Apr 1, 2017 | Dec 31, 2016 | Sep 24, 2016 | Jun 25, 2016 | Mar 26, 2016 | Dec 26, 2015 | Sep 26, 2015 | Jun 27, 2015 | Mar 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 251.3M | 274.1M | 281.8M | 249.2M | 240.3M | 244.6M | 260.7M | 232.4M | 240M | 243.2M | 272M | 256.5M | 244.2M | 271.9M | 265.3M | 294.5M | 260M | 220.4M | 219.5M | 221.3M | 208.8M | 177.1M | 233.4M | 225.5M | 223.5M | 223.4M | 224.6M | 251.6M | 227.4M | 214.3M | 217.4M | 230.3M | 210.9M | 220.8M | 179.8M | 171.2M | 171.5M | 163.2M | 176.4M | 165.9M | 167.4M | 143.3M |
| Selling, General, and Administrative Revenue Growth | -8.32% | -2.73% | +13.08% | +3.70% | -1.76% | -6.18% | +12.18% | -3.17% | -1.32% | -10.59% | +6.04% | +5.04% | -10.19% | +2.49% | -9.92% | +13.27% | +17.97% | +0.41% | -0.81% | +5.99% | +17.90% | -24.12% | +3.50% | +0.89% | +0.04% | -0.53% | -10.73% | +10.64% | +6.11% | -1.43% | -5.60% | +9.20% | -4.48% | +22.80% | +5.02% | -0.17% | +5.09% | -7.48% | +6.33% | -0.90% | +16.82% | n/a |
| Research and Development Revenue | 61.4M | 61.5M | 60.3M | 67.3M | 64.1M | 74.6M | 66.8M | 72.9M | 72.6M | 126.1M | 74.8M | 76M | 65.1M | 69.5M | 72.8M | 76.5M | 69M | 71.5M | 59.3M | 57M | 55.1M | 49.3M | 61.2M | 60.4M | 61.4M | 57.3M | 53.2M | 52.7M | 54.4M | 56.8M | 54.8M | 60.5M | 62.5M | 55.4M | 54.4M | 62.5M | 58.8M | 59.1M | 51.7M | 53.8M | 56M | 53.3M |
| Research and Development Revenue Growth | -0.16% | +1.99% | -10.40% | +4.99% | -14.08% | +11.68% | -8.37% | +0.41% | -42.43% | +68.58% | -1.58% | +16.74% | -6.33% | -4.53% | -4.84% | +10.87% | -3.50% | +20.57% | +4.04% | +3.45% | +11.76% | -19.44% | +1.32% | -1.63% | +7.16% | +7.71% | +0.95% | -3.12% | -4.23% | +3.65% | -9.42% | -3.20% | +12.82% | +1.84% | -12.96% | +6.29% | -0.51% | +14.31% | -3.90% | -3.93% | +5.07% | n/a |
| Sales and Marketing Revenue | 152.2M | 154.4M | 166.1M | 146M | 146.3M | 144.2M | 148.9M | 139.5M | 149.8M | 142.4M | 163.5M | 159.3M | 152.3M | 171.4M | 147.4M | 159.1M | 142.7M | 131.5M | 128M | 125.7M | 103.5M | 110.6M | 144.9M | 141.8M | 143.6M | 133.5M | 146M | 133.5M | 141.1M | 130.5M | 139.5M | 139.7M | 145.4M | 103.4M | 110M | 105.8M | 109M | 100.8M | 99.4M | 99.7M | 94.3M | 83M |
| Sales and Marketing Revenue Growth | -1.42% | -7.04% | +13.77% | -0.21% | +1.46% | -3.16% | +6.74% | -6.88% | +5.20% | -12.91% | +2.64% | +4.60% | -11.14% | +16.28% | -7.35% | +11.49% | +8.52% | +2.73% | +1.83% | +21.45% | -6.42% | -23.67% | +2.19% | -1.25% | +7.57% | -8.56% | +9.36% | -5.39% | +8.12% | -6.45% | -0.14% | -3.92% | +40.62% | -6.00% | +3.97% | -2.94% | +8.13% | +1.41% | -0.30% | +5.73% | +13.61% | n/a |